Cargando…
Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma
(1) Background: We aimed to explore the association between neoadjuvant treatment, tumor-infiltrating immune lymphocyte (TIL), and tumor-associated macrophage (TAM) and survival in patients with esophageal adenocarcinoma. (2) Methods: Patients who underwent esophagectomy were divided into three grou...
Autores principales: | Haddad, Riad, Zlotnik, Oran, Goshen-Lago, Tal, Levi, Mattan, Brook, Elena, Brenner, Baruch, Kundel, Yulia, Ben-Aharon, Irit, Kashtan, Hanoch |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029859/ https://www.ncbi.nlm.nih.gov/pubmed/35455743 http://dx.doi.org/10.3390/jpm12040627 |
Ejemplares similares
-
Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer
por: Zlotnik, Oran, et al.
Publicado: (2021) -
Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
por: Michal, Sternschuss, et al.
Publicado: (2021) -
Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis?
por: Moore, Assaf, et al.
Publicado: (2020) -
Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study
por: Domachevsky, Liran, et al.
Publicado: (2018) -
Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
por: Levi, Mattan, et al.
Publicado: (2020)